Pharmacology

Pharmacology is the study of how chemical substances interact with living systems. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities.

Pharmacology

Pharmacology is the study of the action of drugs on a biologic system. It incorporates components of medicine and biology, and how they interact with each other.

Importance of Pharmacology in Dentistry

Halicin: The AI-Discovered Antibiotic That Fights Superbugs

What is Pharmacoepidemiology?

Opioid Pharmacology

How Can Biochemistry Practices be made Virtual?

Drug Metabolism

Caffeine Pharmacology

DNA and Technology

What is Psychopharmacology?

Hormone Pharmacology

What is Efficacy?

See more featured articles »

Pharmacist Career

Haloperidol Pharmacology

What is Pharmacodynamics?

What is a Dose-Response Curve?

Warfarin Pharmacology

What is Toxicology?

Pharmacology of Paracetamol

Psychopharmacology and Neuropsychopharmacology Research

Synthetic and Patented Cannabinoids

Metabolomics in Pharmacology

Olanzapine Pharmacology

Drug Excretion / Elimination

Pharmacokinetics

Valproic Acid Pharmacology

Calcitonin Pharmacology

Carboplatin Pharmacology

What Are Adaptogens-and Do They Actually Work?

What is Quantitative Systems Pharmacology (QSP) Modeling?

Importance of Allostery in Pharmacology

Morphine Pharmacology

What is Neuropharmacology?

Infliximab Pharmacology

How Nasal Spray Use and Overuse Affects the Nose

What is in Silico?

Geriatric Pharmacology: Medication Management for an Aging Population

Bottom-Up Approach Overview

Nicotine Pharmacology

What is Drug Absorption?

Celebrex (Celecoxib) Pharmacology

Pharmacology of Cannabinoid Receptors

Pharmacology of CAR-T Cells

Drug Distribution

Latest Pharmacology News and Research

Only one in 10 Australians know the Black Triangle safety symbol

Research highlights gaps in awareness of Australia's Black Triangle Scheme, suggesting strategies to enhance understanding and reporting of adverse drug events.

8 Jul 2026

Gut immune cells help prevent severe salmonella infections

Widely recognized as the face of food poisoning, salmonella bacteria lurk in raw meat and poultry, on pets and in unpasteurized dairy products.

7 Jul 2026

New EV-SELEX strategy accelerates drug discovery for wide range of GPCRs

G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, which regulate diverse physiological processes ranging from pain perception to hormone signaling.

7 Jul 2026

Prenatal paracetamol use does not increase child neurodevelopmental risks

Researchers from the University of Hong Kong (HKUMed), along with Aston Pharmacy School's Professor Ian Chi-Kei Wong, have shown that using paracetamol (acetaminophen) during pregnancy does not increase a child's risk of developing autism spectrum disorder (ASD) or attention‑deficit hyperactivity disorder (ADHD).

1 Jul 2026

Many pharmaceutical active ingredients can switch to PFAS-free alternatives

Certain medicines contain per- and polyfluorinated alkyl compounds, known as PFAS, which are causing increasing environmental harm due to their long-lasting effects.

30 Jun 2026

Artificial intelligence improves prediction of cancer drug resistance

A comprehensive review recently published in Current Molecular Pharmacology (2026, Volume 19, Pages 85–96) examines the rapidly evolving landscape of computational tools for predicting tumour drug resistance.

26 Jun 2026

Biognosys showcases next-gen multiomics innovations at ASMS 2026

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics portfolio, highlighting next-generation software, sample preparation, enrichment, and separation technologies for proteomics and metabolomics.

From Biognosys 26 Jun 2026

Natural compound puerarin may protect against cholestatic liver fibrosis

A recent study published in Current Molecular Pharmacology demonstrates that puerarin-a bioactive isoflavone derived from Kudzu root and widely used in traditional Chinese medicine-may offer significant therapeutic benefits against cholestatic liver fibrosis, a progressive pathological condition arising from impaired bile formation and flow that currently lacks effective pharmacotherapies.

25 Jun 2026

Lactate and lactylation play multifaceted roles in pancreatic ductal adenocarcinoma

A comprehensive review recently published in Current Molecular Pharmacology illuminates the pivotal, multifaceted roles of lactate and its downstream protein modification, lactylation, in pancreatic ductal adenocarcinoma (PDAC).

25 Jun 2026

Study uncovers mechanism driving metastasis in aggressive gastric cancer

A study recently published in Current Molecular Pharmacology has uncovered a novel mechanism by which the long non‑coding RNA PVT1 and the translation initiation factor EIF4A1 cooperate to drive gastric cancer metastasis.

25 Jun 2026

Natural bioactive compounds target miR-29a molecule to prevent cancer development

A study published in Current Molecular Pharmacology provides a comprehensive analysis of microRNA-29a (miR-29a) as a pivotal regulator in cancer development, and examines how natural bioactive compounds may offer a promising strategy for cancer prevention by modulating its expression.

25 Jun 2026

Study identifies fPRDM16 as target for age-related pulmonary fibrosis

A study published recently in Current Molecular Pharmacology has uncovered a key mechanism linking aging to persistent pulmonary fibrosis, identifying the transcriptional regulator fPRDM16 as a potential therapeutic target.

25 Jun 2026

New review highlights TREM-1 receptor as target for inflammatory diseases

A comprehensive review recently published in Current Molecular Pharmacology consolidates the growing evidence surrounding the Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) as a central amplifier of innate immune responses and a promising therapeutic target for a range of inflammatory diseases.

25 Jun 2026

Targeted investments can significantly reduce newborn deaths by 2040

A global analysis spanning 194 countries reveals a mixed picture for newborn survival: deaths caused by birth asphyxia, trauma, and prematurity have declined markedly since 2000, yet progress is slowing in many low- and middle-income countries, particularly across sub-Saharan Africa.

25 Jun 2026